Lucas Ward's Stock Ratings

Ascendiant Capital Analyst

Lucas Ward is an analyst at Ascendiant Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/18/2025

Overall Average Return

-48.8%

Smart Score

22.7%

Overall Average Return Percentile

3rd

Number of Ratings

16
Buy NowGet Alert
03/18/2025HSCSBuy Now
HeartSciences
$2.85391.23%
Lucas Ward22%
$15 → $14MaintainsBuyGet Alert
11/27/2024ACONBuy Now
Aclarion
$0.7670.31%
Lucas Ward22%
$555 → $481MaintainsBuyGet Alert
11/25/2024LIQTBuy Now
LiqTech Intl
$1.45120.69%
Lucas Ward22%
$5.15 → $3.2MaintainsBuyGet Alert
11/20/2024VVOSBuy Now
Vivos Therapeutics
$3.6083.33%
Lucas Ward22%
$6.6 → $6.6ReiteratesBuy → BuyGet Alert
09/23/2024HSCSBuy Now
Heart Test Laboratories
$2.85426.32%
Lucas Ward22%
$15 → $15ReiteratesBuy → BuyGet Alert
08/26/2024CYTHBuy Now
Cyclo Therapeutics
$0.6741.79%
Lucas Ward22%
$2.6 → $0.95MaintainsBuyGet Alert
08/26/2024LIQTBuy Now
LiqTech Intl
$1.45255.17%
Lucas Ward22%
$5.15 → $5.15ReiteratesBuy → BuyGet Alert
08/26/2024ACONBuy Now
Aclarion
$0.7696.52%
Lucas Ward22%
$592 → $555MaintainsBuyGet Alert
08/20/2024VVOSBuy Now
Vivos Therapeutics
$3.6083.33%
Lucas Ward22%
$6.4 → $6.6MaintainsBuyGet Alert
07/29/2024VMARBuy Now
Vision Marine
$0.64213.43%
Lucas Ward22%
$337.5 → $270MaintainsBuyGet Alert
07/29/2024ACONBuy Now
Aclarion
$0.76109.62%
Lucas Ward22%
→ $592Initiates → BuyGet Alert
04/22/2024CYTHBuy Now
Cyclo Therapeutics
$0.67288.06%
Lucas Ward22%
→ $2.6Initiates → BuyGet Alert
02/26/2024LIQTBuy Now
LiqTech Intl
$1.45255.17%
Lucas Ward22%
→ $5.15Initiates → BuyGet Alert
10/30/2023VMARBuy Now
Vision Marine
$0.64605.22%
Lucas Ward22%
→ $607.5Initiates → BuyGet Alert
10/02/2023SXTPBuy Now
60 Degrees
$2.1511.63%
Lucas Ward22%
→ $144Initiates → BuyGet Alert
03/06/2023PIXYBuy Now
ShiftPixy
——
Lucas Ward22%
→ $2160Initiates → BuyGet Alert